Published in J Nematol on December 01, 1994
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet (2000) 6.12
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science (2001) 6.00
Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17
Mapping striate and extrastriate visual areas in human cerebral cortex. Proc Natl Acad Sci U S A (1996) 4.69
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology (2002) 4.50
Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol (1996) 4.10
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain (2007) 3.82
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology (2006) 3.60
A neuronal antigen in the brains of Alzheimer patients. Science (1986) 3.49
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology (2004) 3.41
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology (1999) 2.81
The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp Neurol (1999) 2.73
MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology (2008) 2.69
Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol (1997) 2.60
Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol (1993) 2.46
Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology (2008) 2.45
Cockayne syndrome and xeroderma pigmentosum. Neurology (2000) 2.24
The aetiology, pathophysiology and management of chronic orchialgia. BJU Int (2003) 2.24
DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology (2004) 2.12
Rapid immune response to influenza vaccination. Lancet (1993) 2.09
Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol (1986) 2.05
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology (2008) 2.01
Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci (1997) 2.00
Pathology and biology of the Lewy body. J Neuropathol Exp Neurol (1993) 1.99
Isolation and cross-sensitivity of X-ray-sensitive mutants of V79-4 hamster cells. Mutat Res (1987) 1.99
Cloning of a novel member of the low-density lipoprotein receptor family. Gene (1998) 1.97
Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology (2003) 1.97
Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc Natl Acad Sci U S A (1987) 1.96
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology (2010) 1.93
The expression of myosin genes in developing skeletal muscle in the mouse embryo. J Cell Biol (1990) 1.90
Medulloblastoma with glial and rhabdomyoblastic differentiation. A myoglobin and glial fibrillary acidic protein immunohistochemical and ultrastructural study. J Neuropathol Exp Neurol (1983) 1.88
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology (2004) 1.86
A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease. Neuroscience (2007) 1.86
Porphyrin-accumulating mutants of Escherichia coli. J Bacteriol (1973) 1.85
Monoclonal antibodies to Alzheimer neurofibrillary tangles. 1. Identification of polypeptides. Am J Pathol (1985) 1.84
Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology (2006) 1.81
Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol (2000) 1.79
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Monoclonal antibodies to Alzheimer neurofibrillary tangles. 2. Demonstration of a common antigenic determinant between ANT and neurofibrillary degeneration in progressive supranuclear palsy. Am J Pathol (1985) 1.77
Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies. J Thromb Haemost (2008) 1.72
Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol (1996) 1.71
Imaging correlates of pathology in corticobasal syndrome. Neurology (2010) 1.71
Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol (1993) 1.70
Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology (1999) 1.70
Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am J Pathol (1990) 1.67
Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2. Am J Pathol (1987) 1.66
Recurrent epidemic nephritis in South Trinidad. N Engl J Med (1967) 1.63
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol Dis (2010) 1.60
Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol (1996) 1.60
Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology (2011) 1.59
A comparison of Polya and Billroth gastrectomies. Gastroenterology (1965) 1.56
A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease. Neurology (1994) 1.55
Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol (1986) 1.50
Ipsilateral hemisphere activation during motor and sensory tasks. AJNR Am J Neuroradiol (1996) 1.49
Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol (1993) 1.48
Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol (1990) 1.48
Mutations affecting porphyrin biosynthesis in Escherichia coli. Enzyme (1973) 1.47
Clinical and pathologic features of families with LRRK2-associated Parkinson's disease. J Neural Transm Suppl (2006) 1.46
A deficiency in DNA repair and DNA-PKcs expression in the radiosensitive BALB/c mouse. Cancer Res (2000) 1.44
Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res (1995) 1.42
Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase (2005) 1.41
Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol (2000) 1.41
Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol (1990) 1.40
Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol (1994) 1.40
Undiagnosed macroscopic haematuria revisited: a follow-up of 146 patients. BJU Int (2001) 1.40
Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J Neuropathol Exp Neurol (2001) 1.40
Commentary on the Second Event Theory of Busby. Int J Radiat Biol (2000) 1.40
Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. Lab Invest (1992) 1.39
Alpha particle leukaemogenesis. Lancet (1990) 1.38
Suppression of Meloidogyne arenaria Race 1 by Soil Application of Endospores of Pasteuria penetrans. J Nematol (1996) 1.35
Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol (1991) 1.34
Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol (1995) 1.32
Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet (1997) 1.32
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med (2013) 1.31
Functional magnetic resonance imaging mapping of the motor cortex in patients with cerebral tumors. Neurosurgery (1996) 1.31
Morphological and Molecular Characterization of Meloidogyne mayaguensis Isolates from Florida. J Nematol (2004) 1.30
Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol (2003) 1.29
Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology (2009) 1.28
Multigroup diagnosis of electrocardiograms. Comput Biomed Res (1973) 1.28
Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity? Neurology (2009) 1.27
Can nocturnal emergency surgery be reduced? Br Med J (Clin Res Ed) (1984) 1.27
Effect of Tropical Rotation Crops on Meloidogyne incognita and Other Plant-Parasitic Nematodes. J Nematol (1995) 1.27
Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci (1994) 1.27
Cryptococcus neoformans survive and replicate in human microglia. Lab Invest (1995) 1.26
Periodic DNA synthesis in cell-free extracts of Xenopus eggs. EMBO J (1987) 1.26
Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg (1995) 1.25
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration? Neurology (2010) 1.25
Elevated breast cancer risk in irradiated BALB/c mice associates with unique functional polymorphism of the Prkdc (DNA-dependent protein kinase catalytic subunit) gene. Cancer Res (2001) 1.24
Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology (2006) 1.24
The control of DNA replication in a cell-free extract that recapitulates a basic cell cycle in vitro. Development (1988) 1.24
Long-term effects of divorce and remarriage on the adjustment of children. J Am Acad Child Psychiatry (1985) 1.24
Modified Bielschowsky stain and immunohistochemical studies on striatal plaques in Alzheimer's disease. Acta Neuropathol (1990) 1.23
Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology (2005) 1.23
Construction and characterization of a 10-fold genome equivalent rat P1-derived artificial chromosome library. Genomics (1998) 1.22
Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. J Neuropathol Exp Neurol (2001) 1.21